Mycophenolate Mofetil-Induced Cytomegalovirus Colitis in a Patient With Polymyositis.

Autor: Naik ND; Gastroenterology, Edward Via College of Osteopathic Medicine, Blacksburg, USA., Elliott J; Family Medicine, Edward Via College of Osteopathic Medicine, Blacksburg, USA.
Jazyk: angličtina
Zdroj: Cureus [Cureus] 2022 Sep 06; Vol. 14 (9), pp. e28848. Date of Electronic Publication: 2022 Sep 06 (Print Publication: 2022).
DOI: 10.7759/cureus.28848
Abstrakt: As the rate of autoimmune conditions and cancers is increasing in the United States, a larger number of patients are being managed with immunosuppressive medications. Diarrhea is a common problem in immunocompromised patients. A feared complication of immunosuppression is infection with opportunistic pathogens. Cytomegalovirus is an opportunistic infection that can cause infection in a variety of different organ systems, including affecting the gastrointestinal system. Severe infection is most commonly seen as a complication of acquired immunodeficiency syndrome (AIDS), organ transplant, hematological malignancy, or cancer therapy. This case report describes a case of cytomegalovirus colitis in an immunosuppressed patient following mycophenolate mofetil (CellCept) therapy.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2022, Naik et al.)
Databáze: MEDLINE